Pathogen reduction of monkeypox virus in plasma and whole blood using riboflavin and UV light.
<h4>Background</h4>Monkeypox virus has recently emerged from endemic foci in Africa and, since October 20, 2022, more than 73,000 human infections have been reported by the CDC from over 100 countries that historically have not reported monkeypox cases. The detection of virus in skin les...
Main Authors: | Izabela K Ragan, Lindsay M Hartson, Elizabeth J Sullivan, Richard A Bowen, Raymond P Goodrich |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0278862 |
Similar Items
-
Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light.
by: Izabela Ragan, et al.
Published: (2020-01-01) -
Emerging Pathogen Threats in Transfusion Medicine: Improving Safety and Confidence with Pathogen Reduction Technologies
by: Marcia Cardoso, et al.
Published: (2023-07-01) -
Pathogen reduction in human plasma treated with Riboflavin and UV light: impact on coagulation factor VIII
by: Ana Milojković, et al.
Published: (2012-12-01) -
UV-C Light Intervention as a Barrier against Airborne Transmission of SARS-CoV-2
by: Izabela Ragan, et al.
Published: (2024-01-01) -
Pathogen inactivation in fresh frozen plasma using riboflavin and ultraviolet light: Effects on plasma proteins and coagulation factor VIII
by: Stanojković Zoran, et al.
Published: (2011-01-01)